Materna Medical

Materna Medical

What if you could reduce pelvic floor damage, incontinence, and pelvic pain by 60%, removing over $2.2B of cost from women’s healthcare annually? Materna Medical is revolutionizing women’s pelvic health with first-to-market medical devices. Materna’s first product, Milli, launched in 2019 to treat pelvic pain, and pipeline product, Prep, reduced pelvic floor injury by 60% and is in a $2.2M NIH-funded pivotal trial to prevent pelvic floor damage during childbirth. Combined, these devices define a $6B market in women’s health.

Tracy MacNeal